« Previous
Next »
Seminars in Nuclear Medicine
Volume 38, Issue 2
, Pages 141-148
, March 2008
Positron Emission Tomography/Computed Tomography for Target Delineation in Head and Neck Cancers
References
- A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys. 2001;49:907–916
- Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577–587
- Intensity-modulated radiation therapy (IMRT) for locally advanced paranasal sinus tumors: Incorporating clinical decisions in the optimization process. Int J Radiat Oncol Biol Phys. 2003;55:776–784
- Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys. 2004;60:1425–1439
- Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III Randomized Intergroup Study 0099. J Clin Oncol. 1998;16:1310–1317
- Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
- PET and [18F]-FDG in oncology: A clinical update. Nuc Med & Biol. 1996;23:717–735
- Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg:. 2000;126:1457–1461
- Implication of 18F-Fluoro-2-Deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: A Danish cohort study. Laryngoscope. 2002;112:2009–2014
- Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65–72
- . Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med. 2004;45:66S–71S
- FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:129–136
- Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR Imaging, and FDG PET and validation with surgical specimen. Radiology. 2004;233:93–100
- Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys. 2002;53:1051–1057
- Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys. 2003;57:853–863
- Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report. Int J Radiat Oncol Biol Phys. 2004;60:1419–1424
- Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:1385–1392
- Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. Int J Radiat Oncol Biol Phys. 2006;65:726–732
- [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69:286–293
- Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2006;65:143–151
- PET-CT For Target Delineation for Definitive Radiotherapy in Head and Neck Cancers: The Montefiore/Albert Einstein Experience. 2007;Presented at 2007 ACNP Meeting, San Antonio, TX, Feb
- The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers. Int J Radiat Oncol Biol Phys. 2007;68:388–395
- Hypoxia imaging-directed radiation treatment planning. Eur J Nucl Med Mol Imaging. 2006;33:S44–S53
- A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma (Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85). Radiother Oncol. 1998;46:135–146
- . Reporter gene imaging: potential impact on therapy. Nuc Med Biol. 2005;32:763–780
- Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69:541–551
- . Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496–507
- Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65:1315–1322
- The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1001–1010
PII: S0001-2998(07)00140-7
doi: 10.1053/j.semnuclmed.2007.11.002
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Nuclear Medicine
Volume 38, Issue 2
, Pages 141-148
, March 2008
